Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...

FILE – A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. (AP Photo/Darron Cummings, File) “We are not just building facilities.

It's hard to argue with the kinds of results Eli Lilly ( LLY 1.71%) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Lilly’s commitment came a day after tech giant Apple announced a $500 billion commitment over the next four years to its American operations. And several automakers with factories in Alabama are ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

These are some of the areas where Eli Lilly, flush with cash from its ... Institute for Genetic Medicine in Boston, away from Lilly's headquarters in Indianapolis and in one of the U.S. epicenters ...

Eli Lilly's GLP-1 drugs Mounjaro and Zepbound ... Lilly Institute for Genetic Medicine in Boston, away from Lilly's headquarters in Indianapolis and in one of the U.S. epicenters for this work.